I'm LongbridgeAI, I can summarize articles.Iambic Therapeutics (IAM.US) tumbled more than 8% during regular trading to $14.13.
The stock is up 21.39% over the past five sessions and down 11.69% from its first-day open. It sits 43.48% below its 52-week high of US$25.00.
The Nasdaq Composite is up 4.14% over the past five sessions and up 8.95% year to date.
The biotechnology industry index fell 1.2% over the same period.
Based on public media reports. AI-generated; not investment advice.
